Rheumatic Myocarditis Treatment Market - Top Companies and Manufacturers

Companies Dominating the Rheumatic Myocarditis Treatment Landscape

Siemens Healthcare GmbH
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

CryoLife Inc.
Edwards Lifesciences Corporation
Neovasc Inc.
HighLife SAS
Abbott Laboratories
Sanofi-aventis Groupe
Pfizer Inc.
Boston Scientific Corporation
Medtronic PLC

Browse Key Market Insights with Data Illustration:

Rheumatic Myocarditis Treatment Market Size, Growth Forecasts 2024-2036

In the News

Siemens Healthcare GmbH has launched the technologically-advanced multidisciplinary angiography system ARTIS icono. With its development, the company is expected to cater to different needs of cardiovascular interventions, interventional radiology, neuroradiology, and vascular interventions.
Pfizer Inc. has finally acquired Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company that is dedicated to the discovery, development, and delivery of life-changing treatments for patients diagnosed with sickle cell disease (SCD). The acquisition is anticipated to broaden the offerings provided by the company.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of rheumatic myocarditis treatment is assessed at USD 1.1 Billion.

The rheumatic myocarditis treatment market size was valued at USD 1.05 Billion in 2023 and is anticipated to reach USD 1.95 Billion by the end of 2036, registering around 4.9% CAGR during the forecast period i.e., between 2024-2036. Rising prevalence of rheumatic fever and the growing availability of over-the-counter drugs are the major factors driving the market growth.

North America is poised to dominate majority industry share of about 35% by 2036, propelled by increasing frequency of rheumatic fever and subsequently rheumatic myocarditis amongst several people, driven by rising awareness about the disease among people and high healthcare expenditure for treatment procedures.

Siemens Healthcare GmbH, CryoLife Inc., Edwards Lifesciences Corporation, Neovasc Inc., HighLife SAS, Abbott Laboratories, Sanofi-aventis Groupe, Pfizer Inc., Boston Scientific Corporation, Medtronic PLC

Rheumatic Myocarditis Treatment Market - Top Companies and Manufacturers

Companies Dominating the Rheumatic Myocarditis Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the rheumatic myocarditis treatment market worth?

Why is the demand for rheumatic myocarditis treatment growing?

Which region dominated the majority of rheumatic myocarditis treatment industry share?

Who are the top rheumatic myocarditis treatment companies?